MktsMarkets

FibroBiologics, Inc.
NASDAQ: FBLGKey statistics
FBLG News
Stories mentioning FBLG from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 2,953 | 797.00 | 2,789 | 2,041 | 1,780 | 1,356 | 1,213 | 975.00 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 5,068 | 2,590 | 5,038 | 4,490 | 4,531 | 3,711 | 3,352 | 3,224 |
| Operating Income (Loss) | (5,068) | (2,590) | (5,038) | (4,490) | (4,531) | (3,711) | (3,352) | (3,224) |
| Interest Income | 20.00 | 25.00 | 73.00 | 50.00 | 99.00 | 63.00 | 79.00 | 70.00 |
| Interest Expense | 5.00 | |||||||
| Other Expense | (2.00) | 0.00 | 0.00 | 2.00 | 30.00 | |||
| Pretax Income | ||||||||
| Tax Provision | 0.00 | 0.00 | ||||||
| Net Income (Loss) | (5,000) | (3,244) | (5,778) | (4,658) | (4,966) | (3,099) | (500.00) | 898.00 |
| Earnings Per Share (Basic) | (1.33) | (0.07) | (0.13) | (0.12) | (2.71) | (0.09) | (0.01) | 0.03 |
| Earnings Per Share (Diluted) | (1.33) | (0.07) | (0.13) | (0.12) | (2.71) | (0.09) | (0.01) | 0.03 |
| Weighted Average Shares Outstanding (Basic) | 3,773 | 44,661 | 43,073 | 38,635 | 1,834 | 32,875 | 33,517 | 32,719 |
| Weighted Average Shares Outstanding (Diluted) | 3,773 | 44,661 | 43,073 | 38,635 | 1,834 | 32,875 | 33,517 | 32,719 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About FBLG
FibroBiologics, Inc. (NASDAQ: FBLG) is a stock listed on the Nasdaq Stock Market under the ticker symbol FBLG. It last traded at $0.7000 (Nov 20, 2026, 4:00 PM ET), down 15.1% on the day. That gives FibroBiologics a market capitalisation of $7.5M.
Over the past 52 weeks FBLG has traded between $0.6200 and $9.60.
For the quarter ended Mar 31, 2026 it reported a net loss of $5.0M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$5.0M |
| Dec 31, 2025 | — | -$3.2M |
| Sep 30, 2025 | — | -$5.8M |
| Jun 30, 2025 | — | -$4.7M |
From FibroBiologics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…